Journal Pre-proof Anti-inflammatory effects of oral NLRP3 inhibition with ruvonoflast among individuals at elevated cardiovascular risk
FMedSci Kausik K. Ray, Nicholas Clarke, Peter Thornton et al.
· 0 citations
2 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Mortality was lowest at hemoglobin concentrations 1 to 3 g/dL above current WHO thresholds, with higher mortality below and above this range, with higher mortality below and above this range.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.